Alexander Salava

Alexander Salava

Auto-generated profile, based on publicly available information

Alexander Salava

Department of Dermatology and allergology University of Helsinki and Helsinki University Hospital Helsinki Finland

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Clinical and Translational Allergy
Verified
Journal Article
Open access
PDF file
ASAlexander Salava
Alexander Salava
ALAntti Lauerma
Antti Lauerma
Atopic dermatitis (AD) is a common inflammatory skin disorder and characterized by abnormalities in both skin barrier structures and alternations of the immune response. Molecular genetics have dramatically changed our vision of the micro‐organisms colonizing the human skin and recently well‐documented changes in the skin microbiome in atopic dermatitis have become evident. The microbiome shifts have been primarily documented during disease flares and localized to sites of disease predilection, e.g. folds or facial area. In contrast, active treatment has been associated with a recolonisation and higher cutaneous microbial diversity. Additionally to the known dysfunctions in barrier function of the skin (e.g. filaggrin mutations) and immunologic disturbances (e.g. Th2‐shift), evidence is rising that atopic dermatitis is also connected to a dysbiosis of the microbial community without an invading pathogen. In the future the investigation of the patient's skin microbiome may have a foothold in the clinician's diagnostic repertoire and treatment of atopic dermatitis.

1 November 2020 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
ASAlexander Salava
Alexander Salava
PDPaulina Deptula
Paulina Deptula
ALAnnina Lyyski
Annina Lyyski
PLPia Laine
Pia Laine
LPLars Paulin
Lars Paulin
ALAntti Lauerma
Antti Lauerma

12 September 2021 in International Journal of Dermatology
Verified
Journal Article
Open access
PDF file
VKVille Kiiski
Ville Kiiski
ASAlexander Salava
Alexander Salava
PSPäivikki Susitaival
Päivikki Susitaival
SBSatu Barnhill
Satu Barnhill
ARAnita Remitz
Anita Remitz
MHMarkku Heliovaara
Markku Heliovaara
Background: The prevalence of atopic dermatitis (AD) has increased, but studies in adult or elderly populations are sparse.Methods: We investigated 12‐month and lifetime prevalences of AD in the Finnish adult population ≥30 years of age and analyzed living environment factors, socioeconomic factors, lifestyle‐related factors, and serum vitamin D levels for their associations with AD in a national health examination survey.Results: The lifetime prevalence was 21.9% and 12‐month prevalence 10.1%. The highest prevalence (lifetime 28.6%, 12‐month 15.4%) was seen in subjects 30‐39 years of age. Prevalence decreased with age. Subjects with highly educated parents were more likely to have active AD, though there was no effect of higher education in subjects themselves. Younger age and being an ex‐smoker were associated with active AD. Female sex and daily smoking increased the risk in subjects 30‐49 years of age. There was no dose–response relationship to serum vitamin D levels and no association with the living environment.Conclusions: Our data show that the number of adult patients with atopic dermatitis has grown and prevalence numbers of AD in Finnish adults are among the highest reported. Together with the aging of the society, the burden of AD is not limited to childhood.

22 July 2022 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Open access
ASA. Salava
A. Salava
VSV. Salo
V. Salo
JLJ. Leppänen
J. Leppänen
ALA. Lauerma
A. Lauerma
ARA. Remitz
A. Remitz
Background: Severity‐associated factors in atopic dermatitis (AD) have focussed on early onset, concomitant atopic diseases, markers of Th2‐shifted inflammation and filaggrin mutations.Objectives: To investigate factors associated with severe AD in Finnish patients.Methods: We conducted a single‐centre, cross‐sectional observational study with 502 AD patients aged 4.79 to 79.90 years (mean 32.08 years). Disease severity was assessed with the Rajka–Langeland severity score and EASI and associated clinical signs were evaluated. Data regarding onset, relatives, atopic and other comorbidities was gathered retrospectively. We investigated total serum IgE‐levels, a panel of filaggrin null mutations and functional variants of genes associated with skin barrier defects.Results: Factors more frequent in severe AD included early onset (P = 0.004, 95%CI 0.000–0.024), male sex (P = 0.002, 95%CI 0.000–0.11), history of smoking (P = 0.012, 95%CI 0.000–0.024), concomitant asthma (P = 0.001, 95%CI 0.000–0.011), palmar hyperlinearity (P = 0.013, 95%CI 0.014–0.059), hand dermatitis (P = 0.020, 95%CI 0.000–0.029) and history of contact allergy (P = 0.042, 95%CI 0.037–0.096). Body mass indices (P < 0.000, 95%CI 0.000–0.011) and total serum IgE‐levels (P < 0.000, 95%CI 0.000–0.011) were higher in severe AD. No differences were observed for allergic rhinitis, allergic conjunctivitis, food allergy, peanut allergy, prick positivity, keratosis pilaris, history of herpes simplex infections, filaggrin null mutations and other gene variants.Conclusions: Severity determinants in Finnish patients seem to be early‐onset, male sex, smoking, overweight, concomitant asthma, palmar hyperlinearity, hand dermatitis and high IgE‐levels. A sub‐typing of patients in relation to confirmed severity determinants may be useful for course prediction, prognosis and targeted AD management.

15 June 2022 in Acta Dermato-Venereologica
Verified
Journal Article
Open access
ASAlexander Salava
Alexander Salava
RRRuut Rieppo
Ruut Rieppo
ALAntti Lauerma
Antti Lauerma
VSVille Salo
Ville Salo
The burden of atopic dermatitis (AD) appears to be increasing in adult and elderly patients. The aim of this study was to analyse the nationwide database of the Finnish Institute for Health and Welfare regarding the number of patients with AD and of general practitioner consultations in Finland during 2018. The database comprised the main diagnoses of all visits to public primary healthcare. There were 2,094,673 primary care patients (males/females 43.19/56.81%) and 20,905 patients with AD (1.00%) and 24,180 consultations due to AD (0.45%). The highest numbers of patients with AD were in the age groups 0–14 years (9,922 patients, 47.46%) and 15–65 years (9,144 patients, 43.74%). A substantial proportion of patients with AD were aged > 50 years (3,515 patients, 16.81%) or >65 years (1,947 patients, 9.31%). Regression analysis indicated a statistically significant association of age group with patient numbers (p = 0.032) and number of consultations (p = 0.030). There were no differences between direct age group comparisons (p = 0.303), sex (p = 0.389), or number of consultations/patient (p = 0.235). Patients with AD are prevalent in all age groups in Finnish primary care. Patient numbers were also relatively high in groups other than childhood, indicating that age-related distribution in primary care may be shifting to older ages.

3 May 2017 in Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
ASAlexander Salava
Alexander Salava
VAVelma Aho
Velma Aho
ELEmilia Lybeck
Emilia Lybeck
PPPedro Pereira
Pedro Pereira
LPLars Paulin
Lars Paulin
ALAntti Lauerma
Antti Lauerma